Literature DB >> 19040420

P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma.

Lyndsay Davies1, Donna Gray1, Dave Spiller2, Mike R H White2, Bertil Damato3, Ian Grierson1, Luminita Paraoan1.   

Abstract

p53 apoptosis effector related to PMP-22 (PERP) is a transcriptional target gene of p53 tumour suppressor that is specifically induced during apoptosis and not during cell cycle arrest. In primary uveal melanoma (UM), the most common intraocular malignancy in adults that has a reportedly unaffected signalling pathway upstream of and including p53, PERP expression is down-regulated in the metastatic monosomy 3-type tumours, compared with the less aggressive disomy 3-type tumours. Here, we demonstrate experimentally, by the use of full-length PERP-green fluorescent protein (GFP) fusions and real-time confocal microscopy, the intracellular targeting and plasma membrane localization of PERP in living UM cells and show that expression of PERP induces caspase-mediated apoptosis in UM cells. Induction of PERP expression in GFP-PERP-transfected UM cells leads to increased levels of cleaved caspase-8 forms, as well as to reduction of its full-length substrate Bid, but not to detectable processing of caspase-9. The levels of mature caspase-8, -9 and -3 proteins significantly correlate with PERP expression levels in primary UMs. Transcriptional profiling of PERP and caspase-8 in tumour specimens indicates that the positive association of PERP and caspase-8 proteins is a consequence of post-translational processing, most likely at the level of caspase-8 cleavage, and not of increased transcription of pro-caspase-8. We conclude that PERP expression leads to activation of an extrinsic receptor-mediated apoptotic pathway, with a possible subsequent engagement of the intrinsic apoptotic pathway. The findings underline the apoptotic pathway mediated by PERP as a critical mechanism employed by UM tumours to modulate susceptibility to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19040420      PMCID: PMC6529966          DOI: 10.1111/j.1582-4934.2008.00590.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  19 in total

Review 1.  Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.

Authors:  Alexander H Stegh
Journal:  Expert Opin Ther Targets       Date:  2012-01-12       Impact factor: 6.902

2.  Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.

Authors:  Eva A Coenen; C Michel Zwaan; Dirk Reinhardt; Christine J Harrison; Oskar A Haas; Valerie de Haas; Vladimir Mihál; Barbara De Moerloose; Marta Jeison; Jeffrey E Rubnitz; Daisuke Tomizawa; Donna Johnston; Todd A Alonzo; Henrik Hasle; Anne Auvrignon; Michael Dworzak; Andrea Pession; Vincent H J van der Velden; John Swansbury; Kit-fai Wong; Kiminori Terui; Sureyya Savasan; Mark Winstanley; Goda Vaitkeviciene; Martin Zimmermann; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

3.  Transmembrane protein PERP is a component of tessellate junctions and of other junctional and non-junctional plasma membrane regions in diverse epithelial and epithelium-derived cells.

Authors:  Werner W Franke; Hans Heid; Ralf Zimbelmann; Caecilia Kuhn; Stefanie Winter-Simanowski; Yvette Dörflinger; Christine Grund; Steffen Rickelt
Journal:  Cell Tissue Res       Date:  2013-05-21       Impact factor: 5.249

4.  A comparative transcriptomic analysis of uveal melanoma and normal uveal melanocyte.

Authors:  Jianhong An; Haolei Wan; Xiangtian Zhou; Dan-Ning Hu; Ledan Wang; Lili Hao; Dongsheng Yan; Fanjun Shi; Zhonglou Zhou; Jiao Wang; Songnian Hu; Jun Yu; Jia Qu
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

5.  PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells.

Authors:  L Davies; D Spiller; M R H White; I Grierson; L Paraoan
Journal:  Cell Death Dis       Date:  2011-03-31       Impact factor: 8.469

Review 6.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

7.  Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy.

Authors:  Moutushy Mitra; Fahima Dilnawaz; Ranjita Misra; Anju Harilal; Rama Shenkar Verma; Sanjeeb K Sahoo; Subramanian Krishnakumar
Journal:  Cancer Nanotechnol       Date:  2010-12-17

8.  Pemphigus vulgaris autoantibody profiling by proteomic technique.

Authors:  Mina Kalantari-Dehaghi; Grant J Anhalt; Michael J Camilleri; Alex I Chernyavsky; Sookhee Chun; Philip L Felgner; Algis Jasinskas; Kristin M Leiferman; Li Liang; Steve Marchenko; Rie Nakajima-Sasaki; Mark R Pittelkow; John J Zone; Sergei A Grando
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  The type three secreted effector SipC regulates the trafficking of PERP during Salmonella infection.

Authors:  Kelly N Hallstrom; Beth A McCormick
Journal:  Gut Microbes       Date:  2016

10.  PERP, a host tetraspanning membrane protein, is required for Salmonella-induced inflammation.

Authors:  Kelly N Hallstrom; C V Srikanth; Terence A Agbor; Christopher M Dumont; Kristen N Peters; Luminita Paraoan; James E Casanova; Erik J Boll; Beth A McCormick
Journal:  Cell Microbiol       Date:  2015-01-24       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.